Oral Dosage Form New Animal Drugs; Bacitracin Methylene Disalicylate Soluble
other · Food and Drug Administration · Rule · Published 1999-03-17 · Effective 1999-03-17 · 64 FR 13068
Document
Document number
99-6458
Federal Register citation
64 FR 13068
CFR reference
21 CFR 520
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1999-03-17
Effective date
1999-03-17
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for using soluble bacitracin methylene disalicylate (BMD) powder to make a medicated drinking water for replacement chickens as an aid in the prevention and control of necrotic enteritis.